Publications by authors named "U Tim Wu"

Background: Managing disseminated nontuberculous mycobacterial (NTM) infection in patients with neutralizing anti-interferon-γ autoantibodies (AIGAs) poses substantial challenges due to the lack of established treatment guidance and predictive tools for clinical outcomes. In this study, we investigated the utility of F-fluorodeoxyglucose (2-[F]FDG) positron emission tomography (PET) in guiding treatment decisions, with a focus on its ability to predict rehospitalization outcomes.

Methods: We conducted a post hoc analysis of the first available 2-[F]FDG PET scans of patients with AIGAs and disseminated NTM infection from a prospective observational multicenter cohort.

View Article and Find Full Text PDF

The diagnosis of adult-onset immunodeficiency syndrome associated with neutralizing anti-interferon γ autoantibodies (AIGA) presents substantial challenges to clinicians and pathologists due to its nonspecific clinical presentation, absence of routine laboratory tests, and resemblance to certain lymphoma types, notably nodal T follicular helper cell lymphoma, angioimmunoblastic type (nTFHL-AI). Some patients undergo lymphadenectomy for histopathological examination to rule out lymphoma, even in the absence of a preceding clinical suspicion of AIGA. This study aimed to identify reliable methods to prevent misdiagnosis of AIGA in this scenario through a retrospective case-control analysis of clinical and pathological data, along with immune gene transcriptomes using the NanoString nCounter platform, to compare AIGA and nTFHL-AI.

View Article and Find Full Text PDF
Article Synopsis
  • Cutaneous melanoma (CM) is a serious skin cancer, and a study analyzed recent survival rates using data from the SEER database for the years 2004-2018 to understand patient outcomes better.
  • The results revealed that the 5-year relative survival rates improved over the observed years, reaching 95.6% for the 2014-2018 period, with variations based on factors like age, gender, and race.
  • The study predicts that this upward trend in survival rates will continue, estimating a 96.7% survival rate for 2019-2023, highlighting the importance of continuous assessment for better treatment and prevention strategies.
View Article and Find Full Text PDF

Repeated annual influenza vaccinations have been associated with reduced vaccine-induced antibody responses. This prospective study aimed to explore the role of vaccine antigen-specific regulatory T (Treg) cells in antibody response to repeated annual influenza vaccination. We analyzed pre- and postvaccination hemagglutination inhibition (HI) titers, seroconversion rates, seroprotection rates, vaccine antigen hemagglutinin (HA)-specific Treg cells, and conventional T (Tconv) cells.

View Article and Find Full Text PDF

Objective: The purpose of this study was to develop a comprehensive nomogram for the cancer-specific survival (CSS) of white patients with invasive melanoma at back, posterior arm, posterior neck, and posterior scalp (BANS) sites and to determine the validity of the nomogram by comparing it with the conventional American Joint Committee on Cancer (AJCC) staging system.

Methods: This study analyzed the patients with invasive melanoma in the Surveillance, Epidemiology, and End Results (SEER) database. R software was used to randomly divide the patients into training and validation cohorts at a ratio of 7:3.

View Article and Find Full Text PDF